Takeda Pharmaceutical Company Limited - Company & Market Research Reports

Home /
Companies /
Takeda Pharmaceutical Company Limited

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 191
Endocrine and Metabolic Disorders Drugs 162
Gastrointestinal Drugs 148
Central Nervous System Drugs 131
Immune Disorders Drugs 130
Biopharmaceuticals 88
Pharmaceuticals 86
Hematological Drugs 79
Vaccines 78
Drug Discovery 77
Clinical Trials 75
Infectious Diseases Drugs 62
Cardiovascular Drugs 58
Diabetes Drugs 56
Leukemia Drugs 53
Mental Disorders Drugs 46
Lymphoma Drugs 42
Musculoskeletal Disorders Drugs 40
Infusions and Injectables 33
Liver and Kidney Disorders Drugs 33
Over the Counter (OTC) Drugs 31
Lung Cancer Drugs 22
Respiratory Drugs 21
Pharmaceutical Manufacturing 21
Sexual and Reproductive Health Drugs 20
Drug Delivery 19
Antibiotics 16
Analgesics 15
Prostate Cancer Drugs 14
Drugs by Therapeutic Area 13
Immunosuppressive Drugs 13
Pharmaceutical Intermediates 12
Skin Cancer Drugs 12
Schizophrenia Drugs 12
Optical Disorders Drugs 10
Anti-Obesity Drugs 10
Alzheimer's Disease Drugs 9
Generic Drugs 7
Biosimilars and Biosuperiors 7
Psoriasis Drugs 7
Addiction Disorders Drugs 6
Animal Pharmaceuticals 6
Colon Cancer Drugs 6
Thyroid Cancer Drugs 6
Uterine Cancer Drugs 6
Dermatological Drugs 6
Urological Disorders Drugs 6
Brain Cancer Drugs 5
Transdermal and Transmucosal Drug Delivery 5
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Company Reports 3
Breast Cancer Drugs 3
Kidney Cancer Drugs 3
HIV/AIDS Drugs 3
Ovarian Cancer Drugs 2
Cough and Cold Drugs 2
Anesthetic Drugs 2
Cancer Vaccines 2
Pancreatic Cancer Drugs 2
Vitamins and Dietary Supplements 2
Pharmacoeconomics 1
Bladder Cancer Drugs 1
Inhalers and Nebulisers 1
Anxiety Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

1,674 Results (Page 18 of 84)
- Relevance
  Sort by

Cough Hypersensitivity Syndrome Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4008EUR$4,490USD£3,485GBP

Pharyngitis Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4008EUR$4,490USD£3,485GBP

Tracheitis Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4008EUR$4,490USD£3,485GBP

Alpha Mannosidosis Market - Global Forecast 2025-2032

 Report
October 2025
198 Pages
Global

From

€3165EUR$3,545USD£2,752GBP

€3516EUR$3,939USD£3,057GBP

Metabolic Disorders Therapeutics Market - Global Forecast 2025-2032

 Report
October 2025
195 Pages
Global

From

€3165EUR$3,545USD£2,752GBP

€3516EUR$3,939USD£3,057GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Glucosylceramidase Market - Global Forecast 2025-2032

 Report
October 2025
195 Pages
Global

From

€3165EUR$3,545USD£2,752GBP

€3516EUR$3,939USD£3,057GBP

Endocrinology Drugs Market - Global Forecast 2025-2032

 Report
October 2025
182 Pages
Global

From

€3165EUR$3,545USD£2,752GBP

€3516EUR$3,939USD£3,057GBP

2021 Clinical Trial Analytics of the Microbiome Landscape

 Report
April 2021
9 Pages
Global

€1562EUR$1,750USD£1,358GBP

Pharmaceutical Market in Denmark 2025-2029

 Report
March 2025
186 Pages
Denmark

From

€2232EUR$2,500USD£1,940GBP

Crohn's Disease Therapeutics Market Forecast - Epidemiology & Pipeline Analysis

 Report
September 2022
232 Pages
Global

From

€3124EUR$3,500USD£2,717GBP

Obstructive Sleep Apnea (OSA) - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1428EUR$1,600USD£1,242GBP

€1785EUR$2,000USD£1,552GBP

North America Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Country and Growth Forecast, 2023 - 2030

 Report
January 2024
101 Pages
North America

From

€1339EUR$1,500USD£1,164GBP

LAMEA Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Country and Growth Forecast, 2023 - 2030

 Report
January 2024
109 Pages
Africa, Middle East

From

€1339EUR$1,500USD£1,164GBP

Europe Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Country and Growth Forecast, 2023 - 2030

 Report
January 2024
108 Pages
Europe

From

€1339EUR$1,500USD£1,164GBP

Asia Pacific Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Country and Growth Forecast, 2023 - 2030

 Report
January 2024
109 Pages
Asia Pacific

From

€1339EUR$1,500USD£1,164GBP

Over-the-Counter (OTC) Analgesics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
May 2025
183 Pages
Global

From

€4017EUR$4,500USD£3,493GBP

Gaucher Disease Drugs Market Size, Share & Trends Analysis Report by Type (Type 1, Type 2, Type 3, Others) By Therapy (Enzyme Replacement Therapy, Substrate Replacement Therapy, Others), Region, and Segment Forecasts, 2023-2030

 Report
December 2023
84 Pages
Global

From

€5312EUR$5,950USD£4,618GBP

Cystic Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
July 2022
518 Pages
Global

From

€1785EUR$2,000USD£1,552GBP

Metastatic Cancer Drugs - Global Strategic Business Report

 Report
October 2025
377 Pages
Global

From

€5222EUR$5,850USD£4,541GBP

Bortezomib - Global Strategic Business Report

 Report
October 2025
377 Pages
Global

From

€5222EUR$5,850USD£4,541GBP

1,674 Results (Page 18 of 84)
- 1
- 16
- 17
- 18
- 19
- 20

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.